scholarly journals Endophytic fungi from mangrove inhibit lung cancer cell growth and angiogenesis in vitro

2017 ◽  
Vol 37 (3) ◽  
pp. 1793-1803 ◽  
Author(s):  
Xin Liu ◽  
Xin Wu ◽  
Yuefan Ma ◽  
Wenzhang Zhang ◽  
Liang Hu ◽  
...  
2020 ◽  
Vol 19 ◽  
pp. 153303381990111
Author(s):  
Xi Yu ◽  
Hong Zheng ◽  
Rongfei Sun ◽  
Xuejiao Qian ◽  
Ping Jiang ◽  
...  

Lung cancer is the most common cancer type with increasingly high incidence. MicroRNAs provide the potential biomarkers for lung cancer treatment. Thus, we aimed to investigate the function of microRNA-425-5p in lung cancer development and the underlying mechanisms. MicroRNA-425-5p overexpression inhibited A549 lung cancer cell proliferation in vitro and in vivo. On the other hand, microRNA-425-5p inhibition increased A549 proliferation. Mechanistically, the underlying mechanism by which microRNA-425-5p inhibits lung cancer cell growth was mediated through its ability in targeting and downregulating the TFIIB-related factor 2. Our results for the first time identified microRNA-425-5p as a tumor suppressor in lung cancer. Thus, microRNA-425-5p may serve as a potential therapeutic target for lung cancer.


2017 ◽  
Vol 7 (1) ◽  
pp. 65-72 ◽  
Author(s):  
Tiancong Wu ◽  
Ji Geng ◽  
Wenjie Guo ◽  
Jing Gao ◽  
Xixu Zhu

2007 ◽  
Vol 28 (7) ◽  
pp. 1567-1574 ◽  
Author(s):  
Fuzhi Lian ◽  
Donald E. Smith ◽  
Hansgeorg Ernst ◽  
Robert M. Russell ◽  
Xiang-Dong Wang

2015 ◽  
Vol 142 (4) ◽  
pp. 723-732 ◽  
Author(s):  
Runbo Zhong ◽  
Xiaoxiao Ge ◽  
Tianqing Chu ◽  
Jiajun Teng ◽  
Bo Yan ◽  
...  

2017 ◽  
Vol 43 (6) ◽  
pp. 2353-2366 ◽  
Author(s):  
Qian Xiao ◽  
Fang Zheng ◽  
JingJing Wu ◽  
Qing Tang ◽  
Wei Wang ◽  
...  

Background/Aims: Atractylodes macrocephula Koidz is an important ingredient in traditional Chinese herbs. One major bioactive compound, atractylenolide-1 (ATL-1), was reported to have anti-inflammatory and anti-tumor activities. However, the underlying molecular mechanism associated to this has not been well elucidated. Methods: Cell viability and cell cycle distribution were measured using 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) and flow cytometry assays, respectively. Western blot analysis was performed to examine the phosphorylation and protein expression of extracellular signaling-regulated kinase 1/2 (ERK1/2), signal transducer and activator of transcription 3 (Stat3), 3-phosphoinositide dependent protein kinase-1 (PDK1) and transcription factor SP1. QRT-PCR was used to examine the mRNA levels of PDK1 gene. Exogenously expressions of Stat3, PDK1 and SP1 were carried out by transient transfection assays. PDK1 promoter activity was measured by Secrete-Pair Dual Luminescence Assay Kit. A nude mice xenograft model was used to confirm the findings in vitro. Results: We showed that ATL-1 inhibited human lung cancer cell growth and induced cell cycle arrest. Furthermore, we found that ATL-1 stimulated phosphorylation of ERK1/2, inhibited phosphorylation and protein expressions of Stat3 and SP1; the latter were abrogated in the presence of MEK/ERK inhibitor PD98059. Moreover, ATL-1 reduced the protein, mRNA expression and promoter activity of PDK1. Intriguingly, exogenously expressed Stat3 and SP1 overcame ATL-1-inhibited SP1 and Stat3, and PDK1 protein expressions, respectively. Moreover, overexpression of PDK1 resisted the ATL-1-inhibited lung cancer cell growth. In consistent with the results in vitro, ATL-1 inhibited tumor growth, protein expressions of Stat3, SP1 and PDK1, and induced phosphorylation of ERK1/2 in vivo. Conclusion: In summary, our results show that ATL-1 inhibits lung cancer cell growth through activation of ERK1/2, followed by suppressing SP1 protein expression. ATL-1 also reduces phosphorylation and protein levels of Stat3. These are mutual regulation between Stat3 and SP1 proteins affected by ATL-1. This ultimately suppresses PDK1 gene expression. This study reveals a novel mechanism by which ATL-1 inhibits growth of lung cancer cells. Thus, targeting PDK1 pinpoints a potential in the lung cancer treatment.


Oncotarget ◽  
2016 ◽  
Vol 8 (19) ◽  
pp. 30817-30829 ◽  
Author(s):  
Yuanyuan Zeng ◽  
Jianjie Zhu ◽  
Dan Shen ◽  
Hualong Qin ◽  
Zhe Lei ◽  
...  

2018 ◽  
Vol 234 (2) ◽  
pp. 1560-1566 ◽  
Author(s):  
Habib Zarredar ◽  
Shadi Pashapour ◽  
Khalil Ansarin ◽  
Majid Khalili ◽  
Roghayyeh Baghban ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document